前佛均 (Hitoshi Zembutsu) - マイポータル

A Genome-Wide Association Study Identifies Five Novel Genetic Markers for Trastuzumab-Induced Cardiotoxicity in Japanese Population.

Nakano MH, Udagawa C, Shimo A, Kojima Y, Yoshie R, Zaha H, Abe N, Motonari T, Unesoko M, Tamura K …

Biological & pharmaceutical bulletin 42(12) 2045-2053 2019年12月査読有り

Early change in circulating tumor DNA as a potential predictor of response to chemotherapy in patients with metastatic colorectal cancer.

Osumi H, Shinozaki E, Yamaguchi K, Zembutsu H

Scientific reports 9(1) 17358 2019年11月査読有り

Clinical utility of circulating tumor DNA for colorectal cancer.

Osumi H, Shinozaki E, Yamaguchi K, Zembutsu H

Cancer science 110(4) 1148-1155 2019年2月査読有り

Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer.

Osumi H, Shinozaki E, Takeda Y, Wakatsuki T, Ichimura T, Saiura A, Yamaguchi K, Takahashi S, Noda T, Zembutsu H

Cancer medicine 8(1) 408-417 2019年1月査読有り

Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease.

Chihiro Udagawa, Hidehito Horinouchi, Kouya Shiraishi, Takashi Kohno, Takuji Okusaka, Hideki Ueno, Kenji Tamura, Yuichiro Ohe, Hitoshi Zembutsu

PloS one 14(10) e0223371 2019年査読有り

A prospective study to examine the accuracies and efficacies of prediction systems for response to neoadjuvant chemotherapy for muscle invasive bladder cancer.

Yoichiro Kato, Hitoshi Zembutsu, Ryo Takata, Tomohiko Matsuura, Renpei Kato, Mitsugu Kanehira, Kazuhiro Iwasaki, Noriyuki Yamada, Toyomasa Katagiri, Tamotsu Sugai …

Oncology letters 16(5) 5775-5784 2018年11月査読有り

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy

Matthew P. Goetz, Katrin Sangkuhl, Henk-Jan Guchelaar, Matthias Schwab, Michael Province, Michelle Whirl-Carrillo, W. Fraser Symmans, Howard L. McLeod, Mark J. Ratain, Hitoshi Zembutsu …

Clinical Pharmacology and Therapeutics 103(5) 770-777 2018年5月1日査読有り

Breast cancer: The translation of big genomic data to cancer precision medicine

Siew-Kee Low, Hitoshi Zembutsu, Yusuke Nakamura

Cancer Science 109(3) 497-506 2018年3月1日査読有り

Whole exome sequencing to identify genetic markers for trastuzumab-induced cardiotoxicity

Chihiro Udagawa, Hiromi Nakamura, Hiroshi Ohnishi, Kenji Tamura, Tatsunori Shimoi, Masayuki Yoshida, Teruhiko Yoshida, Yasushi Totoki, Tatsuhiro Shibata, Hitoshi Zembutsu

Cancer Science 109(2) 446-452 2018年2月1日査読有り

Targeted sequencing reveals genetic variants associated with sensitivity of 79 human cancer xenografts to anticancer drugs.

Chihiro Udagawa, Yasushi Sasaki, Hiroshi Suemizu, Yasuyuki Ohnishi, Hiroshi Ohnishi, Takashi Tokino, Hitoshi Zembutsu

Experimental and therapeutic medicine 15(2) 1339-1359 2018年2月査読有り

A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study.

Onishi H, Udagawa C, Kubo M, Nakamura S, Akashi-Tanaka S, Kuwayama T, Watanabe C, Takamaru T, Takei H, Ishikawa T …

PloS one 13(8) e0201606 2018年査読有り

Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer

Hiroaki Taniguchi, Daisuke Hoshino, Chiharu Moriya, Hitoshi Zembutsu, Nobuhiro Nishiyama, Hiroyuki Yamamoto, Kazunori Kataoka, Kohzoh Imai

ONCOTARGET 8(29) 46856-46874 2017年7月査読有り

The prediction models for postoperative overall survival and disease-free survival in patients with breast cancer

Daichi Shigemizu, Takuji Iwase, Masataka Yoshimoto, Yasuyo Suzuki, Fuyuki Miya, Keith A. Boroevich, Toyomasa Katagiri, Hitoshi Zembutsu, Tatsuhiko Tsunoda

CANCER MEDICINE 6(7) 1627-1638 2017年7月査読有り

Significant Effect of Polymorphisms in CYP2D6 on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter Study

Hitoshi Zembutsu, Seigo Nakamura, Sadako Akashi-Tanaka, Takashi Kuwayama, Chie Watanabe, Tomoko Takamaru, Hiroyuki Takei, Takashi Ishikawa, Kana Miyahara, Hiroshi Matsumoto …

CLINICAL CANCER RESEARCH 23(8) 2019-2026 2017年4月査読有り

Overview of the BioBank Japan Project: Study design and profile

Akiko Nagai, Makoto Hirata, Yoichiro Kamatani, Kaori Muto, Koichi Matsuda, Yutaka Kiyohara, Toshiharu Ninomiya, Akiko Tamakoshi, Zentaro Yamagata, Taisei Mushiroda …

JOURNAL OF EPIDEMIOLOGY 27(3) S2-S8 2017年3月査読有り

Overview of BioBank Japan follow-up data in 32 diseases

Makoto Hirata, Akiko Nagai, Yoichiro Kamatani, Toshiharu Ninomiya, Akiko Tamakoshi, Zentaro Yamagata, Michiaki Kubo, Kaori Muto, Yutaka Kiyohara, Taisei Mushiroda …

JOURNAL OF EPIDEMIOLOGY 27(3) S22-S28 2017年3月査読有り

Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseases

Makoto Hirata, Yoichiro Kamatani, Akiko Nagai, Yutaka Kiyohara, Toshiharu Ninomiya, Akiko Tamakoshi, Zentaro Yamagata, Michiaki Kubo, Kaori Muto, Taisei Mushiroda …

JOURNAL OF EPIDEMIOLOGY 27(3) S9-S21 2017年3月査読有り

Pharmacogenomics toward personalized tamoxifen therapy for breast cancer

Hitoshi Zembutsu

PHARMACOGENOMICS 16(3) 287-296 2015年査読有り

Lymph node shape in computed tomography imaging as a predictor for axillary lymph node metastasis in patients with breast cancer

Goro Kutomi, Tousei Ohmura, Fukino Satomi, Tomoko Takamaru, Hiroaki Shima, Yasuyo Suzuki, Seiko Otokozawa, Hitoshi Zembutsu, Mitsuru Mori, Koichi Hirata

EXPERIMENTAL AND THERAPEUTIC MEDICINE 8(2) 681-685 2014年8月査読有り

VAV3 mediates resistance to breast cancer endocrine therapy

Helena Aguilar, Ander Urruticoechea, Pasi Halonen, Kazuma Kiyotani, Taisei Mushiroda, Xavier Barril, Jordi Serra-Musach, Abul Islam, Livia Caizzi, Luciano Di Croce …

Breast Cancer Research 16(3) R53 2014年5月28日査読有り

前佛均

基本情報

論文

メニュー